Gujarat Akruti - Tcg Biotech Profile
Key Indicators
- Authorised Capital ₹ 11.00 Cr
as on 15-05-2024
- Paid Up Capital ₹ 0.50 M
as on 15-05-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 93.36%
(FY 2016)
- Profit -27.35%
(FY 2016)
- Ebitda -38.74%
(FY 2016)
- Net Worth -3.80%
(FY 2016)
- Total Assets 37.94%
(FY 2016)
About Gujarat Akruti - Tcg Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Prasanta Biswal, Rushank Shah, and Dattatraya Prabhu serve as directors at the Company.
- CIN/LLPIN
U70102GJ2007PLC050966
- Company No.
050966
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
28 May 2007
- Date of AGM
12 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Gujarat Akruti - Tcg Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rushank Shah  | Director | 12-Mar-2015 | Current |
| Prasanta Biswal | Director | 28-May-2007 | Current |
| Dattatraya Prabhu | Director | 16-Apr-2021 | Current |
Financial Performance of Gujarat Akruti - Tcg Biotech.
Gujarat Akruti - Tcg Biotech Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 93.36% increase. The company also saw a substantial fall in profitability, with a 27.35% decrease in profit. The company's net worth dipped by a decrease of 3.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gujarat Akruti - Tcg Biotech?
In 2017, Gujarat Akruti - Tcg Biotech had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Hubtown Bus Terminal (Adajan) Private LimitedActive 16 years 8 months
Dattatraya Prabhu is a mutual person
- Hubtown Bus Terminal (Mehsana) Private LimitedActive 16 years 8 months
Dattatraya Prabhu is a mutual person
- Hubtown Bus Terminal (Ahmedabad) Private LimitedActive 15 years 22 days
Dattatraya Prabhu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gujarat Akruti - Tcg Biotech?
Unlock and access historical data on people associated with Gujarat Akruti - Tcg Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gujarat Akruti - Tcg Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gujarat Akruti - Tcg Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
